# IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/il-6-and-pd-l1-antibody-blockade-combination-therapy-reduces-tumour-progression/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas A. Mace,Reena Shakya,Jason R. Pitarresi,Benjamin Swanson,Christopher McQuinn,Shannon Loftus,Emily Nordquist,Zobeida Cruz‐Monserrate,Lianbo Yu,Gregory Young,Xiaoling Zhong,Teresa A. Zimmers,Michael C. Ostrowski,Thomas Ludwig,Mark Bloomston,Tanios Bekaii‐Saab,Gregory B. Lesinski |
| Citations | 548 |
| DOI | 10.1136/gutjnl-2016-311585 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://gut.bmj.com/content/gutjnl/67/2/320.full.pdf |
| OpenAlex ID | https://openalex.org/W2537220355 |
| PMID | 27797936 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Gregory Young](https://scholariq.org/researchers/gregory-young/)
- [Gregory B. Lesinski](https://scholariq.org/researchers/gregory-b-lesinski/)

## Paper journal

- [Gut](https://scholariq.org/journals/gut/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Chemokine receptors and signaling](https://scholariq.org/topics/chemokine-receptors-and-signaling/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.